Sobre el 70% de los casos se produce después de un procedimiento dental Palabras clave: osteonecrosis, bifosfonatos, osteonecrosis de los maxilares. os riscos das condições orais e sistêmicas que envolvem o uso de bifosfonatos. para tratar a estos pacientes en las distintas especialidades odontologicas. La prevalencia de avulsión dental supone del 0, % de todas las lesiones .. (58), acetazolamida (59), bifosfonatos (60,61)o derivado de la matriz del.

Author: Jusida Mishakar
Country: Ethiopia
Language: English (Spanish)
Genre: Travel
Published (Last): 25 October 2004
Pages: 11
PDF File Size: 19.14 Mb
ePub File Size: 3.29 Mb
ISBN: 585-6-20534-630-9
Downloads: 4155
Price: Free* [*Free Regsitration Required]
Uploader: Tell

Seguridad de los bifosfonatos

Novel antiogenic effects of the bisphosphonate compound Zoledronic acid. Injury ; 39 2: Osteocyte apoptosis controls activation of intracortical resorption in response to bone fatigue.

The bisphosphonate ibandronate accelerates osseointegration of hydroxyapatite-coated cementless implants in an animal model. Farnesol and geranylgeraniol prevent activation of caspases by aminobisphosphonates: Sin embargo, es importante recordar que los bifosfonatos disminuyen la tasa total de fracturas.

Skeletal Radiol ; Joint Bone Spine, Drug Saf ; 29 2: Managing the care of patients with bisphosphonate-associated osteonecrosis: From molds and macrophages to mevalonate: Safety of oral bisphosphonates: Am J Ophthalmol ; Endodontic implications of bisphosphonate-associated osteonecrosis of the jaws: Possible delayed onset of osteonecrosis of the jaw in association with zoledronic acid. J Oral Maxillofac Surg, 61pp.

  CMOS 40106 PDF

Acta Oncol Stockholm, Sweden ; Odontologiia Bone Miner Res, 13pp.

The managment of Paget’s disease of bone. J Oral Maxillofac Surg, 62pp. Treatment of osteoporosis with biphosphonates. Endocrinology ; 4: Osteonecrosis de los maxilares. Bisphosphonates are widely indicated, and most therapies using bisphosphonates are given long-term, which has favored the emergence of new associated adverse effects — maxillary osteonecrosis MONsevere pain, atypical fractures, stomatitis, and inflammatory eye disorders.

Int J Oral Maxillofac Surg, 35pp.

Boosting effect of bisphosphonates on osteoconductive materials: Rheum Dis Clin North Am ; IARC Scientific publications odonrologia Ann Pharmacother ; 39 4: Biphosphonates and fractures of the subtrochanteric or diaphyseal femur.

The presence of other risk factors should be taken into account, and patients should be surveilled on an individual basis for the potential emergence of heart rhythm disturbances. J Clin Periodontol ; Breast Cancer Res ; 4: These drugs might be associated with the growing of spontaneous ulceration of the oral mucosa and osteonecrosis of the jaws.

In recent years, due to different causes, an increasing number of patients are under medical treatment with bisphosphonates. Bol Inf farmacoter Navar ; 17 5: No se pueden establecer conclusiones definitivas, debido fundamentalmente a la escasez de estudios y heterogeneidad de los mismos.

Oral odontollgia and risk of cancer of oesophagus, stomach, and colorectum: Pamidronate disodium and possible ocular adverse drug reactions. Discovery, clinical development, and therapeutic uses of bispophonates. Scleritis and other ocular side effects associated with pami-dronate disodium. Int Een Oral Maxillofac Implants, 21pp.


Protocolo de atendimento para pacientes com osteonecrose by on Prezi

Calcif Tissue Int ; Posible association between diabetes and bisphosphonate-related jaw osteonecrosis. Vidal 1C. Medina 2 y L.

Osteonecrosis of jaw in patient with hormone-refractory prostate cancer treated with zoledronic acid. Valorar los factores de riesgo asociados que puedan favorecer los efectos adversos comentados y poner en el otro lado de la balanza el riesgo de fracturas.

Osteonecrosis de los Maxilares Asociado a Terapia con Bifosfonatos: Situación Actual

Bisphosphonate use and the risk of adverse jaw outcomes: Alendronate and Atrial Fibrillation. Adverse effects of bisphosphonates. In this group of selected patients with recurrent lithiasis and osteopenia the treatment with biphosphonates alone or associated with thiazide diuretics has given good results in renal lithiasis control bifosfonatps bone demineralization.